Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,618.00
Bid: 1,582.00
Ask: 1,695.00
Change: 0.00 (0.00%)
Spread: 113.00 (7.143%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 22nd Apr 2013 07:20

Admiral Group: Deutsche Bank takes target price from 1140p to 1300p retaining a hold recommendation.African Barrick Gold: Deutsche Bank ups target price from 173p to 180p staying with its hold recommendation.Albemarle & Bond: Canaccord Genuity reduces target price from 280p to 146p and downgrades from a speculative buy to hold.Anglo American: Deutsche Bank cuts target price from 2210p to 2170p, while its buy recommendation remains unaltered. HSBC Holdings moves target price from 2240p to 2250p and maintains an overweight rating.Antofagasta: HSBC Holdings moves target price from 1160p to 1080p and reiterates a neutral rating.AstraZeneca: Credit Suisse increases target price from 3050p to 3130p and maintains an underperform rating.BHP Billiton: HSBC Holdings reduces target price from 2250p to 2110p, while upgrading to overweight. Espirito Santo cuts target price from 1703p to 1605p, while upgrading to neutral.Brooks Macdonald: Canaccord Genuity revises target price from 1540p to 1620p keeping a buy recommendation.Brown (N) Group: HSBC Holdings takes target price from 430p to 485p and retains an overweight rating.Burford Capital: Espirito Santo revises target price from 149p to 140p and stays with its buy recommendation.Cable & Wireless Communications: Jefferies shifts target price from 40p to 42p and retains a hold recommendation.Chariot Oil & Gas: UBS cuts target price from 70p to 20p downgrading from buy to neutral.Electrocomponents: Goldman Sachs reduces target price from 311p to 277p and downgrades to neutral.Eurasian Natural Resources: Exane BNP raises target price from 270p to 320p staying with a neutral rating.GlaxoSmithKline: Credit Suisse increases target price from 1450p to 1670p and reiterates its neutral rating.Hansteen Holdings: Espirito Santo lowers target price from 76p to 85p maintaining a neutral rating.Ithaca Energy: Westhouse Securities ups target price from 165p to 200p and reiterates a buy recommendation. RBC Capital increases target price to 225p and keeps an outperform rating.Kazakhmys: Credit Suisse upgrades from underperform to neutral with its target price at 450p. Exane BNP increases target price from 350p to 390 upgrading to neutral.Legal & General Group: Deutsche Bank ups target price from 170p to 189p keeping a buy recommendation.Lloyds Banking Group: RBC Capital shifts target price from 69p to 65p and reiterates an outperform rating.NetDimensions: Sanlam Securities restarts with a target price of 80p and a buy recommendation.New World Resources: Exane BNP cuts target price from 180p to 165p and leaves its underperform rating unchanged.Premier Farnell: Goldman Sachs lowers target price from 240p to 226p and downgrades to neutral.Prudential: Deutsche Bank increases target price from 1060p to 1240p maintaining its buy recommendation.Reckitt Benckiser: Canaccord Genuity takes target price from 3425p to 4100p, but still recommends selling.Regus: JP Morgan shifts target price from 135p to 140p, while downgrading to underweight.Rentokil Initial: Deutsche Bank moves target price from 76p to 100p reiterating a hold recommendation.Resolution: Deutsche Bank lowers target price from 285p to 273p and keeps a hold recommendation.Rio Tinto: HSBC Holdings cuts target price from 4180p to 4160p, while its overweight rating remains unchanged. Espirito Santo raises target price from 2910p to 3160p and upgrades to neutral.Sagentia Group:Westhouse Securities downgrades from add to neutral with a target price of 107p.Segro: Espirito Santo shifts target price from 247p to 250p and leaves its neutral rating unchanged.Spectris: Goldman Sachs cuts target price from 3250p to 2850p maintaining a strong buy recommendation. Credit Suisse reduces target price from 2670p to 2350p and retains an outperform rating. UBS takes target price from 2700p to 2500p, while leaving its buy recommendation unchanged. Bank of America moves target price from 2080p to 1980p and keeps an underperform rating. JP Morgan reduces target price from 2575p to 2455p, while its overweight rating remains unchanged.Spirent Communications: Jefferies reduces target price from 196p to 140p keeping a buy recommendation. Investec places its target price (prev. 175p) under review reiterating its buy recommendation. Canaccord Genuity lowers target price from 135p to 120p and retains a hold recommendation.St James's Place: Deutsche Bank raises target price from 485p to 525p, while keeping a hold recommendation.Sweett Group: WH Ireland shifts target price from 27p to 33p and moves from a speculative buy to a buy rating.Talk Talk Telecom: Jefferies moves target price from 270p to 284p and maintains a buy recommendation. Credit Suisse raises target price from 200p to 275p and retains an outperform rating.Travis Perkins: Goldman Sachs downgrades from strong buy to buy with a target price of 1708p.Vedanta Resources: HSBC Holdings reduces target price from 1310p to 1280p and maintains its neutral rating.Vodafone Group: Jefferies shifts target price from 174p to 179p keeping a hold recommendation.Whitbread: Credit Suisse increases target price from 2760p to 2900p reiterating an outperform rating.William Hill: Nomura shifts target price from 333p to 339p and stays with its reduces rating. JP Morgan moves target price from 485p to 490p keeping an overweight rating.
More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.